Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Sysmex America, LabCorp sign hematology automation agreement

Sysmex America (SAI), a medical diagnostic instrument manufacturer and information systems developer, has signed a five-year agreement with Laboratory Corporation of America Holdings (LabCorp), to provide fully automated hematology systems for LabCorp's primary testing laboratories.

LabCorp has purchased Sysmex HST-N hematology automation systems comprised of XE-Series automated hematology analyzers, Sysmex SP-1000i automated slidemaker/stainers and Sysmex-distributed CellaVision DM96 automated digital cell morphology systems.  

Sysmex WAM decision support software for the Clinical Laboratory will bring rules-based intelligence to the automation systems by consolidating data from the multiple instruments and performing expert rules-based functions and results management.  

The HST-N systems, linked to the AutoSorter II by Motoman, will also utilise Sysmex’ RU-10 reagent production system, specifically designed for the Commercial Reference Laboratory.

Sysmex America president and CEO John Kershaw said that they are honored to serve as LabCorp’s strategic business partner in its endeavor to provide a new ‘intelligent’ diagnostic service offering.

“We trust our innovative automated solutions will provide an unparalleled level of optimization that streamlines operations while providing quality, connectivity and an enhanced service offering,” Kershaw said.